iSpeak Blog

Testing Focused on Improving System and Product Quality using Critical Thinking and Risk-Based Decision-Making

Gabriela Kantor
GampGPG7-Testing3_coming-soon-750px.jpg

In today’s highly regulated life sciences environment, computerized systems play a vital role in supporting patient safety, product quality, and data integrity. Whether managing manufacturing operations, clinical data, laboratory processes, pharmacovigilance activities, or quality systems, organizations depend on these technologies to execute critical business processes reliably and compliantly. As systems become increasingly complex, effective testing is more important than ever. However, modern testing is no longer about generating excessive documentation. It is about providing meaningful assurance that a system is fit for its intended use.

ISPE’s latest industry Guide, ISPE GAMP® Good Practice Guide: Testing of GxP Systems (Third Edition), emphasizes a significant shift in mindset. Testing should focus on improving system and product quality through critical thinking and risk-based decision-making, rather than simply producing evidence for audits and inspections.

Testing is one of the most important verification activities within the computerized system lifecycle. Alongside requirements definition, governance, training, risk management, and quality processes, testing provides objective evidence that a system performs as intended and meets user requirements.

More importantly, testing serves as the primary mechanism for identifying defects before a system enters operational use. By detecting issues early, organizations reduce the potential impact on patient safety, product quality, and data integrity. Effective testing also verifies that risk controls are functioning properly and that identified risks have been reduced to an acceptable level.

This lifecycle perspective is critical. Testing should not be viewed as a standalone activity performed at the end of a project. Instead, it should be integrated throughout the system lifecycle, from implementation through operation, upgrades, and eventual retirement.

Moving Beyond Documentation-Driven Testing

Historically, many validation programs have placed a strong emphasis on generating extensive test documentation. While documentation remains important, modern guidance encourages organizations to focus on assurance rather than paperwork.

The amount of testing performed should not be determined solely by software category classifications. Instead, testing effort should be scaled based on:

  • Potential impact on patient safety
  • Impact on product quality
  • Impact on data integrity
  • System complexity and novelty
  • Business process risk

This approach aligns with both ISPE GAMP® 5 (Second Edition) and the FDA’s Computer Software Assurance (CSA) guidance, which advocate for testing strategies that provide the greatest assurance with the most efficient use of resources.

The key question is no longer, “How much documentation can we create?” Instead, organizations should ask, “What level of testing is necessary to demonstrate that this system is fit for its intended use?”

The Critical Role of Quality Risk Management

Quality risk management (QRM) is at the heart of modern testing practices. QRM provides a systematic approach to identifying, assessing, controlling, monitoring, and reviewing risks throughout the system lifecycle.

Risk assessments help organizations determine:

  • Which system functions are most critical
  • Where testing effort should be concentrated
  • Which controls require verification
  • How much evidence is necessary to support validation decisions

Testing and risk management are closely connected. Risk assessments identify critical controls, while testing verifies that those controls operate effectively.

This relationship creates a powerful feedback loop. Risk assessments guide test design, and test results confirm whether risk mitigation measures are working as intended. If testing reveals weaknesses, organizations can refine controls and update risk assessments accordingly.

Applying Critical Thinking to Testing

One of the most important themes in the new testing guidance is the application of critical thinking.

Critical thinking means making informed, science-based decisions rather than relying on rigid templates or historical practices. It requires teams to understand the business process, evaluate the actual risk, and determine the most effective approach to testing.

By applying critical thinking, organizations can right-size their testing efforts while maintaining confidence in system quality.

The Future of GxP Testing

The evolution of GxP testing reflects broader changes in technology, regulatory expectations, and quality management practices. Modern validation programs are embracing risk-based decision-making, supplier collaboration, incremental development, cloud technologies, automated testing tools, and continuous improvement principles.

Success no longer comes from performing the most testing or generating the largest validation package. Success comes from implementing smart, risk-based testing strategies that focus on what matters most.

By combining QRM, critical thinking, lifecycle management, and effective supplier collaboration, organizations can achieve a higher level of assurance while reducing unnecessary effort. The result is a more efficient validation process, faster adoption of innovation, and ultimately, stronger protection of patient safety, product quality, and data integrity.

GET THE GUIDE


Guidance Documents

Produced by pharmaceutical manufacturing industry professionals, ISPE Guidance Documents provide the practical, real-world information you need to help your company build on current best practices to meet and exceed regulatory standards. ISPE Members receive a discount on Guidance Documents.

Search Guides

References